Effects of simulated bleeding in an in vitro nasal fibroblast wound healing model

Am J Rhinol Allergy. 2010 May-Jun;24(3):186-91. doi: 10.2500/ajra.2010.24.3452.

Abstract

Background: We investigated the effect of simulated bleeding on plasminogen activity, matrix metalloproteinase (MMP) expression, and wound healing using a human fibroblast model.

Methods: Nasal fibroblasts from three chronic rhinosinusitis (CRS) patients with nasal polyps and three controls were grown in culture and a standardized injury was created using a punch. To mimic bleeding, fibroblasts were stimulated with plasminogen (100 microg/mL), plasminogen + tranexamic acid (TA; 100 microg/mL) or media only. At 24, 48, and 72 hours after injury, we measured urokinase plasminogen activator (uPA) and tissue-type plasminogen activator (tPA) activities and inactive and active MMP-2 and -9 expression.

Results: Injury stimulated the nasal fibroblasts to express uPA and tPA and active and inactive MMP-2 and -9. In CRS patients, plasminogen significantly decreased MMP-9 expression after 48 hours (p < 0.04). In untreated fibroblasts, we observed a decrease in active MMP-9 expression, whereas plasminogen increased active MMP-9 expression after 48 hours (p < 0.04). At 24 hours, active MMP-9 expression was reduced by plasminogen +/- TA (p < 0.02). Plasminogen also stimulated uPA expression in CRS patient fibroblasts after 48 hours (p < 0.04). Fibroblast proliferation occurred when exposed to plasminogen and was strongly modulated by uPA and inactive and active MMP-2. The quality of wound healing was affected by inactive MMP-2, uPA and tPA, simulation, and inhibition of bleeding.

Conclusion: Activation of the plasminogen pathway and inactive MMP-2 expression tended to increase both proliferation of nasal fibroblasts and MMP-9 expression as a marker for deterioration of the quality of wound healing.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Biomarkers / metabolism
  • Cell Proliferation / drug effects
  • Cells, Cultured
  • Chronic Disease
  • Fibroblasts / drug effects
  • Fibroblasts / metabolism*
  • Fibroblasts / pathology
  • Hemorrhage / chemically induced
  • Hemorrhage / genetics
  • Hemorrhage / metabolism*
  • Hemorrhage / pathology
  • Hemorrhage / physiopathology
  • Humans
  • Matrix Metalloproteinase 2 / biosynthesis
  • Matrix Metalloproteinase 2 / genetics
  • Matrix Metalloproteinase 9 / biosynthesis
  • Matrix Metalloproteinase 9 / genetics
  • Nose / injuries*
  • Nose / pathology
  • Plasminogen / pharmacology
  • Rhinitis / genetics
  • Rhinitis / metabolism*
  • Rhinitis / pathology
  • Rhinitis / physiopathology
  • Sinusitis / genetics
  • Sinusitis / metabolism*
  • Sinusitis / pathology
  • Sinusitis / physiopathology
  • Tissue Plasminogen Activator / biosynthesis
  • Tissue Plasminogen Activator / genetics
  • Tranexamic Acid / pharmacology
  • Urokinase-Type Plasminogen Activator / biosynthesis
  • Urokinase-Type Plasminogen Activator / genetics
  • Wound Healing / drug effects

Substances

  • Biomarkers
  • Tranexamic Acid
  • Plasminogen
  • Tissue Plasminogen Activator
  • Urokinase-Type Plasminogen Activator
  • Matrix Metalloproteinase 2
  • Matrix Metalloproteinase 9